ShareValue scores for 688089.SHG: Valuation 61, Quality 56, Growth 29, Health 31.
688089.SHGSSE
Cabio Biotech Wuhan Co Ltd
CN¥7.73
(-0.64%)
688089.SHGSSE
Cabio Biotech Wuhan Co Ltd
CN¥7.73(-0.64%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Weak
Health:Stressed
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
3% to 16%
Rating
Trap Risk
Return
3% to 16%
Valuation
61
Fair Value
Price vs Value
Quality
56
Moderate
Business Strength
Growth
29
Weak
Revenue & Earnings
Health
31
Stressed
Financial Stability
Momentum
35
Bearish
Price Trend
Company Details
About
Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. It offers human and animal nutrition, personal care, and synthetic biology products. The company was founded in 1999 and is based in Wuhan, the People's Republic of China.
Market Cap$1.30B
P/E Ratio32.2
Dividend YieldNone
Sector Rank#2410
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026